Vigeo Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Vigeo Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors (NCT03364400) | Vigeo Therapeutics, Inc. | 2017-11-28 |
Track Vigeo Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.